Philip L Johnson insider trades

Open-market stock purchases and sales by Philip L Johnson, EVP & Chief Financial Officer at Jazz Pharmaceuticals plc, from SEC Form 4 filings since Mar 1, 2024.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +105%.

Recent trades

DateStockTradeValue
Mar 5, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$493K
Feb 26, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—

Companies traded

  • JAZZ Jazz Pharmaceuticals plc: 1 buy, last Mar 5, 2026

Get free alerts when Philip L Johnson files a new trade →